ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) CEO Philippe Deschamps discusses a new partnership the company has formed with the California Medical Innovations Institute (CALMI2) with Proactive's Stephen Gunnion.
As an initial step, Deschamps says ChitogenX will work with the institute on demonstrating the effectiveness of its biopolymer platelet-rich plasma (PRP) in regenerative medicine delivery, helping to validate the company's programs.
#ProactiveInvestors #ChitogenX #CaliforniaMedicalInnovationsInstitute #CALM12 #CSE #OTCQB